Radioisotopes Research Today is a free monthly online journal that collates and summarizes the latest research about Radioisotopes, including details on radioimmunotherapy, radionuclides, procedures, hazards.

Radioiodine in the treatment of thyroid cancer.

Van Nostrand D, Wartofsky L

Division of Nuclear Medicine, Washington Hospital Center, and Georgetown University Medical Center, Washington, DC 20010, USA. douglas.van.nostrand@medstar.net

This article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients who have well differentiated thyroid cancer. We review definitions; staging; the two-principal methods for selection of a dosage of 131-I for ablation and treatment; the objectives of ablation and treatment; the indications for ablation and treatment; the recommendations for the use of 131-I for ablation and treatment contained in the Guidelines of the American Thyroid Association, the European Consensus, the Society of Nuclear Medicine, and the European Association of Nuclear Medicine; the dosage recommendations and selection of dosage for 131-I by the these organizations; and the Washington Hospital Center approach.

Published 3 August 2007 in Endocrinol Metab Clin North Am, 36(3): 807-22, vii-viii.
Full-text of this article is available online (may require subscription).

© 2005-2008 Radioisotopes Research Today. All Rights Reserved.